Literature DB >> 28259607

Refining megatherapy, improving outcome in neuroblastoma.

Rochelle Bagatell1, Stephan A Grupp2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28259607     DOI: 10.1016/S1470-2045(17)30069-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.

Authors:  Steve E Braunstein; Wendy B London; Susan G Kreissman; Judith G Villablanca; Andrew M Davidoff; Kenneth DeSantes; Robert P Castleberry; Kevin Murray; Lisa Diller; Katherine Matthay; Susan L Cohn; Barry Shulkin; Daniel von Allmen; Marguerite T Parisi; Collin Van Ryn; Julie R Park; Michael P La Quaglia; Daphne A Haas-Kogan
Journal:  Pediatr Blood Cancer       Date:  2019-04-09       Impact factor: 3.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.